KFDA to reshuffle drug review standards substantially.

KFDA intends to set up more detailed plans for the quality assurance of drugs on the market and its safety controls by adopting a new system for those drugs to be reviewed in its safety and efficacy at any time without giving any advanced notification so far in practice, for the inducement of an appropriate drug use and the prevention of any possible adverse reactions.

Under the advanced not...